Matthew Yglesias @mattyglesias
Pavloxid is very promising but the current production plans aren’t nearly big enough to be our salvation if vaccines fail in the face of a new variant — this is “treat rare breakthrough infections” numbers not “give it to everyone” territory. https://t.co/MNmWvxG5rC — PolitiTweet.org